semaglutide fairfax Weight Loss Treatment Semaglutide Weight Loss Injections in

Learn about Ozempic (Semaglutide) for type 2 diabetes treatment & weight management

Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity.

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157

It plays a key role in regulating GLP-1 production, helping to control appetite and support natural weight management

Bloating can be a side effect of semaglutide and other GLP-1 medications

Retatrutide altered circulating metabolites and lipids linked to fatty acid oxidation and insulin resistance in people with obesity, with or without type 2 diabetes